These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 15634933)

  • 1. TNF receptor-associated factor 6 is an essential mediator of CD40-activated proinflammatory pathways in monocytes and macrophages.
    Mukundan L; Bishop GA; Head KZ; Zhang L; Wahl LM; Suttles J
    J Immunol; 2005 Jan; 174(2):1081-90. PubMed ID: 15634933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways.
    Pearson LL; Castle BE; Kehry MR
    Int Immunol; 2001 Mar; 13(3):273-83. PubMed ID: 11222496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
    Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
    J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competition between TRAF2 and TRAF6 regulates NF-kappaB activation in human B lymphocytes.
    Zhang W; Zhang X; Wu XL; He LS; Zeng XF; Crammer AC; Lipsky PE
    Chin Med Sci J; 2010 Mar; 25(1):1-12. PubMed ID: 20449947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mechanism for TNFR-associated factor 6-dependent CD40 signaling.
    Rowland SL; Tremblay MM; Ellison JM; Stunz LL; Bishop GA; Hostager BS
    J Immunol; 2007 Oct; 179(7):4645-53. PubMed ID: 17878362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile.
    Lutgens E; Lievens D; Beckers L; Wijnands E; Soehnlein O; Zernecke A; Seijkens T; Engel D; Cleutjens J; Keller AM; Naik SH; Boon L; Oufella HA; Mallat Z; Ahonen CL; Noelle RJ; de Winther MP; Daemen MJ; Biessen EA; Weber C
    J Exp Med; 2010 Feb; 207(2):391-404. PubMed ID: 20100871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular responses to murine CD40 in a mouse B cell line may be TRAF dependent or independent.
    Manning E; Pullen SS; Souza DJ; Kehry M; Noelle RJ
    Eur J Immunol; 2002 Jan; 32(1):39-49. PubMed ID: 11754002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs.
    Pullen SS; Dang TT; Crute JJ; Kehry MR
    J Biol Chem; 1999 May; 274(20):14246-54. PubMed ID: 10318845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells.
    Schwabe RF; Schnabl B; Kweon YO; Brenner DA
    J Immunol; 2001 Jun; 166(11):6812-9. PubMed ID: 11359840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 signaling of monocyte inflammatory cytokine synthesis through an ERK1/2-dependent pathway. A target of interleukin (il)-4 and il-10 anti-inflammatory action.
    Suttles J; Milhorn DM; Miller RW; Poe JC; Wahl LM; Stout RD
    J Biol Chem; 1999 Feb; 274(9):5835-42. PubMed ID: 10026206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40.
    Tsukamoto N; Kobayashi N; Azuma S; Yamamoto T; Inoue J
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1234-9. PubMed ID: 9990007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation.
    Pype S; Declercq W; Ibrahimi A; Michiels C; Van Rietschoten JG; Dewulf N; de Boer M; Vandenabeele P; Huylebroeck D; Remacle JE
    J Biol Chem; 2000 Jun; 275(24):18586-93. PubMed ID: 10764746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages.
    Park DR; Thomsen AR; Frevert CW; Pham U; Skerrett SJ; Kiener PA; Liles WC
    J Immunol; 2003 Jun; 170(12):6209-16. PubMed ID: 12794152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
    Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
    Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor receptor-associated factor 6 (TRAF6) stimulates extracellular signal-regulated kinase (ERK) activity in CD40 signaling along a ras-independent pathway.
    Kashiwada M; Shirakata Y; Inoue JI; Nakano H; Okazaki K; Okumura K; Yamamoto T; Nagaoka H; Takemori T
    J Exp Med; 1998 Jan; 187(2):237-44. PubMed ID: 9432981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
    Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of CD40-TRAF2,3 or CD40-TRAF6 is sufficient to inhibit pro-inflammatory responses in non-haematopoietic cells.
    Portillo JA; Greene JA; Schwartz I; Subauste MC; Subauste CS
    Immunology; 2015 Jan; 144(1):21-33. PubMed ID: 25051892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor of cytokine signaling 1 inhibits cytokine induction of CD40 expression in macrophages.
    Wesemann DR; Dong Y; O'Keefe GM; Nguyen VT; Benveniste EN
    J Immunol; 2002 Sep; 169(5):2354-60. PubMed ID: 12193701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.
    Loniewski KJ; Patial S; Parameswaran N
    Mol Immunol; 2007 Jul; 44(15):3715-23. PubMed ID: 17507094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An 11-amino acid sequence in the cytoplasmic domain of CD40 is sufficient for activation of c-Jun N-terminal kinase, activation of MAPKAP kinase-2, phosphorylation of I kappa B alpha, and protection of WEHI-231 cells from anti-IgM-induced growth arrest.
    Sutherland CL; Krebs DL; Gold MR
    J Immunol; 1999 Apr; 162(8):4720-30. PubMed ID: 10202013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.